Biogen Inc. (BIIB) News Headlines

▮ More

Date

Headline

11/27/2020 7:58:01 AM Biogen, Sage Therapeutics To Jointly Develop And Commercialize Zuranolone, SAGE-324

11/27/2020 7:35:27 AM Biogen And Sage Therapeutics Execute Global Collaboration And License Agreement

11/9/2020 4:49:37 PM William Blair Reiterates Biogen Inc. (BIIB) At Market Perform

11/8/2020 9:52:03 AM Week Ahead In Pharma: FDA Decisions, SITC Presentations, 13D SEC Filing

11/5/2020 12:11:01 AM BIIB Faces FDA Panel Tomorrow, CRSP Climbs On Hemoglobinopathies Trial Data, SAVA On Watch

11/1/2020 5:00:11 AM Week Ahead In Pharma: COVID-19 Data Readout, FDA Decisions, CTAD Presentation

10/26/2020 1:45:58 AM Biotech Stocks Facing FDA Decision In November 2020

10/21/2020 7:26:35 AM Biogen Trims FY20 Earnings Outlook; Q3 Results Top Estimates - Quick Facts

10/21/2020 7:06:01 AM Biogen Q3 GAAP EPS $4.46; Non-GAAP EPS $8.84

9/14/2020 8:20:12 AM Biogen Announces $250 Mln, 20-yr Initiative To Eliminate Fossil Fuels - Quick Facts

9/14/2020 7:42:09 AM Biogen Announces Groundbreaking $250 Mln, 20-yr Initiative To Eliminate Fossil Fuels

8/7/2020 10:13:59 AM Stock Alert: Biogen Ticking Up

8/7/2020 8:07:11 AM Biogen: FDA To Review Biologics License Application For Aducanumab

8/7/2020 7:59:40 AM Biogen: FDA Accepts Aducanumab BLA For Alzheimer's Disease With Priority Review

8/6/2020 9:50:21 AM Denali Stock Surges After Biogen Collaboration

8/6/2020 8:55:37 AM Biogen, Denali To Co-develop Small Molecule Inhibitors Of LRRK2 For Parkinson's Disease.

7/22/2020 7:31:53 AM Biogen Inc. (BIIB) Has Lowered Its FY20 Revenue Estimate To $13.8 - $14.2 Bln From $14.0 - $14.3 Bln

7/22/2020 7:30:28 AM Biogen Inc. (BIIB) Has Raised Its FY20 EPS Estimate To 34.00 - 36.00 From 31.50 - 33.50

7/22/2020 7:24:47 AM Biogen Boosts FY20 Earnings Outlook; Q2 Results Top Estimates - Quick Facts

7/22/2020 7:05:15 AM Biogen Q2 EPS $9.59 Vs $7.85 Last Year